Enzychem Lifesciences Corporation (183490.KQ) KOE

1,071.00

+11(+1.04%)

Updated at October 20 10:56AM

Currency In KRW

Valuation

Market Cap116.79B
Enterprise Value111.37B
P/E Ratio-3.69
PEG Ratio-7.37
Price/Sales Ratio1.13
Price/Book Ratio0.54
Enterprise/Revenue1.02
Enterprise/EBITDA-4.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.31
Operating Margin-0.19

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.14

Income Statement

Revenue77.38B
Revenue/Share926.71
Gross Profit4.31B
EBITDA-18.39B
Net Income-22.11B
Diluted EPS-269.72

Balance Sheet

Total Cash112.27B
Total Cash/Share1,430.9
Total Debt4.12B
Total Debt/Equity0.03
Current Ratio17.29
Book Value Per Share1,968.22

Price History

52-Week Change-29.23
52-Week High1,714
52-Week Low937
Moving Average 50 Days1,074.02
Moving Average 200 Days1,191.77

Statistics

Average Volume673,286.5
Shares Outstanding77.63M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor6:1
Last Split DateAugust 17, 2022